Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (4)

Company Market Cap Price
DNA Ginkgo Bioworks Holdings, Inc.
Precision Fermentation & Synthetic Biology aligns with engineering microbes and synthetic biology platforms.
$760.33M
$12.99
+8.16%
EXOZ eXoZymes, Inc.
Direct major product category: precision fermentation and synthetic biology platform enabling cell-free production of chemicals and biologics.
$120.50M
$13.77
+8.89%
DYAI Dyadic International, Inc.
C1 and Dapibus are microbial protein production platforms enabling precision fermentation for high-yield, animal-free proteins across life sciences, food & nutrition, and bio-industrial markets.
$34.00M
$1.14
-2.56%
ZIVO ZIVO Bioscience, Inc.
Employs precision fermentation/synthetic biology to produce bioactive compounds from algae.
$24.38M
$14.00

Loading company comparison...

Loading research report...

DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Extends Strategic Partnership with Bayer to Accelerate Agricultural Biologicals

Oct 31, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Announces Collaboration with STRM.BIO and UBC to Develop In‑Vivo CAR Therapies Under ARPA‑H EMBODY Program

Oct 23, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium for AI-Driven Biologics Discovery

Sep 04, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Settles Shareholder Derivative Actions for $4.125 Million

Aug 29, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Datapoints Partners to Deploy AI-Driven Lab-in-the-Loop Workflows for Biopharma

Aug 20, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Drive External Growth

Aug 12, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Reports Q2 2025 Financial Results, Achieves $250 Million Cost Savings Target Early

Aug 07, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Automation Secures $4.66 Million Contract with PNNL for Microbial Research Automation

Jul 30, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Launches Cost-Competitive US-Based ADME Profiling Service

Jul 17, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. Added to Multiple Russell Indexes

Jun 29, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Appoints Steven Coen as Chief Financial Officer

May 21, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks and Twist Bioscience Revise Collaboration Agreement

May 08, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Reports Q1 2025 Financial Results, Reaffirms Full Year Guidance

May 06, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks and Phytolon Achieve Milestone, Nearly Tripling Natural Food Color Production Efficiency

Apr 30, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Automation Partners with Aura Genetics to Scale Direct-to-Consumer Diagnostic Testing

Apr 22, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks and Partners Awarded $29 Million ARPA-H Contract for Pharmaceutical Supply Chain Stabilization

Apr 10, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Partners with Plex Research for AI-Powered Drug Discovery

Apr 03, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Reports Q4 and Full Year 2024 Financial Results, Issues 2025 Guidance

Feb 25, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Integrates Volta Labs' Callisto System for Enhanced NGS Workflows

Feb 21, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Secures Up to €24 Million European Biosecurity Project for Agnostic Diagnostics

Feb 20, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Automation to Deploy Flexible Lab System at Great Lakes Bioenergy Research Center

Jan 23, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Partners with Astellas' Universal Cells for iPSC-Derived Cell Therapies

Jan 13, 2025
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Awarded $9.4 Million ARPA-H Subcontract for Bioelectronic Devices

Dec 17, 2024
DNA Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Achieves $9 Million Milestone in Merck Biologics Manufacturing Collaboration

Nov 12, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks